Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial

Pregnancy and Childbirth

Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial

Am J Obstet Gynecol.

Sharma C, Soni A, Gupta A, Verma A, Verma S

doi: 10.1016/

Pregnancy and Childbirth

Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure

Am J Obstet Gynecol.

Catherine Tolcher M, Fox KA, Sangi-Haghpeykar H, Clark SL, Belfort MA

doi: 10.1016/j.ajog.2020.06.018.

Pregnancy and Childbirth

Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial

BMJ.

Wennerholm UB, Saltvedt S, Wessberg A, Alkmark M, Bergh C, Wendel SB, Fadl H, Jonsson M, Ladfors L, Sengpiel V, Wesström J, Wennergren G, Wikström AK, Elden H, Stephansson O, Hagberg H

doi: 10.1136/bmj.l6131.

Oral misoprostol for induction of labour in hypertensive pregnancies

Lancet.

Suri V, Sikka P

doi: 10.1016/

Pregnancy and Childbirth

Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network meta-analysis

doi: 10.1016/j.ajog.2020.03.016.

Pregnancy and Childbirth

Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial

Am J Obstet Gynecol.

Blue NR, Murray-Krezan C, Drake-Lavelle S, Weinberg D, Holbrook BD, Katukuri VR, Leeman L, Mozurkewich EL

doi: 10.1016/j.ajog.2018.02.016.

Pregnancy and Childbirth

Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

Lancet.

Chappell LC, Brocklehurst P, Green ME, Hunter R, Hardy P, Juszczak E, Linsell L, Chiocchia V, Greenland M, Placzek A, Townend J, Marlow N, Sandall J, Shennan A, PHOENIX Study Group.

doi: 10.1016/S0140-6736(19)31963-4.

Pregnancy and Childbirth

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Lancet.

Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y, Roberts TE, Ogwulu CO, Williams E, Jones LL, La Fontaine Papadopoulos JH, Bender-Atik R, Brewin J, Hinshaw K, Choudhary M, Ahmed A, Naftalin J, Nunes N, Oliver A, Izzat F, Bhatia K, Hassan I, Jeve Y, Hamilton J, Deb S, Bottomley C, Ross J, Watkins L, Underwood M, Cheong Y, Kumar CS, Gupta P, Small R, Pringle S, Hodge F, Shahid A, Gallos ID, Horne AW, Quenby S, Coomarasamy A

doi: 10.1016/S0140-6736(20)31788-8.

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Lancet.

Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A

doi: 10.1016/

Related content

Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial

Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure

Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial

Oral misoprostol for induction of labour in hypertensive pregnancies

Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network meta-analysis

Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial

Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial